Cardiopulmonary bypass has a modest association with cancer progression: A retrospective cohort study

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Pinto, Cathy A ^a   Marcella, Stephen ^a   August, David A ^b   Holland, Bart ^c   Kostis, John B ^d   Demissie, Kitaw ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cancer progression; Cardiopulmonary bypass; Population based cohort study

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OFF PUMP CORONARY SURGERY; OPEN HEART SURGERY; POPULATION RESEARCH; POPULATION SIZE; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; DISEASE PROGRESSION; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK;

EID: 84886733322     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-519     Document Type: Article

References (20)

1. Sablotzki A, Welters I, Lehmann N, Menges T, Gorlach G, et al. Plasma levels of immunoinhibitory cytokine interleukin-10 and transforming growth factor-β in patients undergoing coronary artery bypass grafting. Eur J Cardio Thorac Surg 1997, 11(4):763-768.
2. Markewitz A, Lante W, Franke A, Marohl K, Kuhlmann WD, Weinhold C. Alterations of cell mediated immunity following cardiac operations: clinical implications and open questions. Shock 2001, 16(Suppl 1):10-15.
3. Viera RD, Pereira AC, Lima EG, Garzillo CL, Rezende PC, et al. Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study. Coronary Artery Diesase 2012, 23:79-84.
4. Mistiaen W, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg 2004, 77:1593-1597. 10.1016/j.athoracsur.2003.08.049, 15111148.
5. Carrascal Y, Gualis J, Arevalo A, Fulquet E, Florez S, Rey J. Cardiac surgery with extracorporeal circulation in cancer patients: influence on surgical morbidity and mortality on survival. Rev Esp Cardiol 2008, 61(4):369-375. 10.1157/13117728, 18405517.
6. Platell C. Influence of cardiopulmonary bypass surgery on cancer-specific survival rate of patients with colorectal cancer. Dis Colon Rectum 1998, 41:1371-1375. 10.1007/BF02237052, 9823802.
7. Suzuki S, Usui A, Yoshida K, Matsuura A, Ichihara T. Effect of cardiopulmonary bypass on cancer prognosis. Asian Cardiovasc Thorac Ann 2010, 18:536-540. 10.1177/0218492310388453, 21149401.
8. The Cardiovascular Institute of New Jersey MIDAS - Myocardial Infarction Data Acquisition System (MIDAS) http://rwjms.umdnj.edu/cvinj/Research/MIDAS_1.html Accessed June 4, 2011.
9. State of New Jersey Department of Health and Senior Services Cardiac Surgery Registry http://www.state.nj.us/health/healthcarequality/cardiacsurgery.shtml. Accessed June 4, 2011.
10. State of New Jersey Department of Health and Senior Services New Jersey State Cancer Registry (NJSCR) 2011, http://www.nj.gov/health/ces/. Accessed June 4, 2011.
11. Redelings MD, Wise M, Sorvillo FC. Using Multiple Cause-of-Death Data to Investigate Associations and Causality Between Conditions Listed on the Death Certificate. Am J Epidemiol 2007, 166:104-108. 10.1093/aje/kwm037, 17426040.
12. Rosenbaum PR, Rubin DB. The central role of the propensity, score in observational studies for causal effects. Biometrika 1983, 79:516-524.
13. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, et al. Variable selection for propensity score models. Am J Epidemiol 2006, 163:1149-1156. 10.1093/aje/kwj149, 1513192, 16624967.
14. Westreich D, Cole SR, Funk MJ, Brookhart A, Stuermer T. The role of the c-statistic in the variable select for propensity score models. Pharmacoepidemiol Drug Saf 2011, 20:317-320. 10.1002/pds.2074, 3081361, 21351315.
15. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007, 26:2389-2430. 10.1002/sim.2712, 17031868.
16. Lin DY, Wei LJ. The robust inference for the proportional hazards model. Journal of the American Statistical Assocation 1989, 84:1074-1078.
17. Harrell F, Lee K. Verifying assumptions of the proportional hazards model. Proceedings of the eleventh annual SAS users'group international 1986, 823-828.
18. Gerlini G, Romagnoli P, Pimpinelli N. Skin cancer and immunosuppression. Crit Rev Oncol Hematol 2005, 56:127-136. Elsevier Ireland Ltd. Available at: http://ac.els-cdn.com/S1040842805000910/1-s2.0-S1040842805000910-main.pdf?_tid=bc91744a-31d7-11e3-a216-00000aacb362&acdnat=1381429020_442946be3f049ec6081886577f16d347. Accessed on October 10, 2013., 10.1016/j.critrevonc.2004.11.011, 15978830.
19. Crespo-Leiro, Villa-Arranz A, Manito-Lorie N, Paniagua-Martin MJ, Rabago G, et al. Lung Cancer After Heart Transplantation. Results from a Large Multicenter Registry. Am J Transplant 2011, 11:1035-1040. 10.1111/j.1600-6143.2011.03515.x, 21521471.
20. Kirk GD, Merlo C, Driscoll PO, Mehta SH, Galai N, et al. HIV Infection is Associated with an Increased Risk for Lung Cancer, Independent of Smoking. Clin Infect Dis 2007, 45(1):103-110. 10.1086/518606, 17554710.